GlaxoSmithKline (GSK) Fails to deliver data

Key failure to deliver metrics for GlaxoSmithKline:

• Last SEC data release: 2024-10-11
• Last 15 days FTD volume: NZ$4.81 M
• Last 3 months FTD volume: NZ$25.51 M
• Last year FTD volume: NZ$25.51 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for GlaxoSmithKline (GSK) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for GlaxoSmithKline (GSK) - since 2022

GlaxoSmithKline (GSK) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
AstraZeneca AZN	NZ$24.35 M	NZ$0.15 B	🇬🇧 UK
Pfizer PFE	NZ$0.18 B	NZ$0.53 B	🇺🇸 USA
Merck MRK	NZ$21.36 M	NZ$84.84 M	🇺🇸 USA
Novartis NVS	NZ$16.44 M	NZ$78.49 M	🇨🇭 Switzerland
Sanofi SNY	NZ$9.72 M	NZ$72.48 M	🇫🇷 France
Teva Pharmaceutical Industries TEVA	NZ$8.56 M	NZ$30.89 M	🇮🇱 Israel
Dynavax Technologies DVAX	NZ$7.96 M	NZ$32.01 M	🇺🇸 USA